Treatment options for patients with large cell neuroendocrine carcinoma of the lung
- PMID: 24719260
- PMCID: PMC4042022
- DOI: 10.1007/s11748-014-0379-9
Treatment options for patients with large cell neuroendocrine carcinoma of the lung
Abstract
Large cell neuroendocrine carcinoma (LCNEC) of the lung is categorized as a variant of large cell carcinomas, and LCNEC tumors display biological behaviors resembling those of small cell lung carcinomas and features of high-grade neuroendocrine tumors. Because patients with LCNEC have a poor prognosis, surgery alone is not sufficient. Multimodality therapies, including adjuvant chemotherapy, appear promising for improved prognosis in patients with LCNEC. In this review article, we discuss treatment options for patients with LCNEC of the lung.
Similar articles
-
Treatment of lung large cell neuroendocrine carcinoma.Tumour Biol. 2016 Jun;37(6):7047-57. doi: 10.1007/s13277-016-5003-4. Epub 2016 Mar 4. Tumour Biol. 2016. PMID: 26943800 Review.
-
Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.Ann Thorac Surg. 2007 Aug;84(2):702-7. doi: 10.1016/j.athoracsur.2007.03.093. Ann Thorac Surg. 2007. PMID: 17643676 Review.
-
A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6. doi: 10.1093/ejcts/ezr132. Epub 2011 Dec 21. Eur J Cardiothorac Surg. 2012. PMID: 22219429
-
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.Anticancer Drugs. 2010 Jan;21(1):89-93. doi: 10.1097/CAD.0b013e328330fd79. Anticancer Drugs. 2010. PMID: 19770636 Clinical Trial.
-
Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.J Thorac Cardiovasc Surg. 2013 Mar;145(3):839-46. doi: 10.1016/j.jtcvs.2012.03.036. Epub 2012 Apr 11. J Thorac Cardiovasc Surg. 2013. PMID: 22498090
Cited by
-
TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.Cell Death Differ. 2019 Jul;26(7):1235-1250. doi: 10.1038/s41418-018-0202-8. Epub 2018 Sep 25. Cell Death Differ. 2019. PMID: 30254375 Free PMC article.
-
Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report.Onco Targets Ther. 2019 Feb 18;12:1359-1364. doi: 10.2147/OTT.S189858. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863102 Free PMC article.
-
Treatment of lung large cell neuroendocrine carcinoma.Tumour Biol. 2016 Jun;37(6):7047-57. doi: 10.1007/s13277-016-5003-4. Epub 2016 Mar 4. Tumour Biol. 2016. PMID: 26943800 Review.
-
Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.Intern Med. 2017;56(6):719-724. doi: 10.2169/internalmedicine.56.7768. Epub 2017 Mar 17. Intern Med. 2017. PMID: 28321077 Free PMC article.
-
Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.Thorac Cancer. 2018 Feb;9(2):273-277. doi: 10.1111/1759-7714.12576. Epub 2017 Dec 22. Thorac Cancer. 2018. PMID: 29271588 Free PMC article.
References
-
- Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64:413–421. - PubMed
-
- World Health Organization . Histological typing of lung and pleural tumours. 3. Bochum: Springer; 1999.
-
- Travis WD, Rusch W, Flieder DB, Falk R, Fleming MV, Gal AA, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934–944. doi: 10.1097/00000478-199808000-00003. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical